News

  • As usual, our lab presents multiple posters and platform presentations and receive several awards at the Annual Meeting of Society of Toxicology. Congratulations to the entire team for another great year! Our lab’s accomplishments have been featured at the college’s website here. The awards are listed here. Please refer to the SOT Program for details of our presentations. (03/22/2022)
  • Ning’s manuscript entitled “Comparative pharmacokinetics of sulfadiazine and its metabolite N4-acetyl sulfadiazine in grass carp (Ctenopharyngodon idella) at different temperatures after oral administration” has been accepted by Pharmaceutics. Congratulations! (03/22/2020)
  • Congratulations to Gabriel on his new position as a Senior Scientist in the ADME & Discovery Group at Merch in Boston, MA. Gabriel will start this new position in March. We are very proud of you. (02/25/2022)
  • Qiran’s manuscript entitled “Integration of Toxicogenomics and Physiologically Based Pharmacokinetic (PBPK) Modeling in Human Health Risk Assessment of Perfluorooctane Sulfonate (PFOS)” has been accepted by Environmental Science & Technology. Congratulations! (02/11/2022)
  • Qiran, Wei-Chun, and Long receive the Postdoctoral Fellow Poster Awards of the 2021 Annual Meeting of Southeastern Society of Toxicology (SESOT). Congratulations to all! (12/20/2021)
    • Qiran’s poster title is “The Implementation of Toxiocogenomics and Physiologically Based Pharmacokinetic (PBPK) modeling to the Human Health Risk Assessment of Perfluorooctane Sulfonate (PFOS)”.
    • Wei-Chun’s poster title is “A web-based platform based on a generic physiologically based pharmacokinetic (PBPK) model to predict withdrawal intervals of flunixin, florfenicol, and penicillin G in cattle and swine”.
    • Long’s poster title is “A web-based interactive physiologically based pharmacokinetic (iPBPK) model for meloxicam in domestic chickens”.
  • Dr. Lin delivers a webinar entitled “Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling in Nanomedicine, Food Safety and Human Health Risk Assessment and Roles of Artificial Intelligence (AI) Approaches in these Areas”. This is part of the webinar series hosted by ScitoVation, Durham, NC. The recording is available here. (12/07/2021)
  • Dr. Lin is named in the World’s Top 2% Scientists List in 2020 published by Stanford University. Here is the full citation information of this list. “Baas, Jeroen; Boyack, Kevin; Ioannidis, John P.A. (2021), “August 2021 data-update for “Updated science-wide author databases of standardized citation indicators””, Mendeley Data, V3, doi: 10.17632/btchxktzyw.3”. (11/22/2021)
  • Riad’s last day with UF. Congratulations again to Riad! (10/29/2021)Riad Lab Photo
  • Our lab receives a new subcontract from The Children’s Hospital of Philadelphia (CHOP). The objective of this subcontract is to identify efficient sampling interval to effectively construct time-concentration profile of bisphenol A in the infant’s urine using a PBPK model. This new subcontract becomes part of the existing subcontract between CHOP and UF that is led by the PI Dr. Eric Coker. Dr. Lin is Co-PI of this subcontract. (10/06/2021)
  • Our lab’s R01 grant is featured on PHHP website. Check it out here. This news has also been picked up by Nano Magazine and NanoWerk. (09/30/2021).
  • Dr. Lin gives a seminar entitled “Application of Pharmacometrics in Veterinary Medicine and Translation of Pharmacokinetics/Pharmacodynamics from Animals to Humans” as part of the EGH seminar series. A recorded presentation is available upon request. (09/30/2021)
  • Riad has accepted a new position as Senior Quantitative Systems Pharmacologist 1 in AbbVie in North Chicago, IL. Riad completed his postdoc training within only a little bit more than one year. During this time, he received the Andersen-Clewell Trainee Award of Biological Modeling Specialty Section and Risk Assessment Specialty Section of Society of Toxicology, and he published one manuscript in Toxicological Sciences. He also completed the manuscript draft of his second major project and had great progress on his third project. Congratulations to Riad and thanks to his contributions to the lab! (09/27/2021)
  • Our lab receives a new subaward to develop a PBPK model for PFOS in daily cows from University of California-Davis. (09/10/2021)
  • Our lab receives our first R01 grant from NIH. This grant is based on extensive foundational work from our lab in the last several years. Thanks to the contributions from prior and current lab members and collaborators. Congratulations to all! (09/01/2021)NIBIB
  • Gabriel has completed his training at UF and returned back to his home university. This summer, Gabriel learned PBPK modeling and developed a PBPK model for irinotecan in mice and humans as part of his PhD dissertation. (08/22/2021)
  • Dr. Lin has completed the UF First Year Faculty Teaching Academy (FYFTA) program. This is part of the preparation to develop and teach new courses at UF beginning in 2022. (08/04/2021)
  • Riad’s manuscript entitled “Development and Application of an interactive Physiologically Based Pharmacokinetic (iPBPK) Model to Predict Oxytetracycline Tissue Distribution and Withdrawal Intervals in Market-Age Sheep and Goats” has been accepted by Toxicological Sciences. Congratulations! (07/27/2021)
  • The UF Component of the Food Animal Residue Avoidance Databank (FARAD) Program has received the 2021 Award. Congratulations to the entire FARAD team! (07/20/2021)
  • Gabriel has joined our lab as a Visiting PhD Student. Welcome! (07/12/2021)
  • Dr. Lin and all his lab members have moved to the University of Florida. (05/28/2021)

Click here for news archives from 2016 to 2021 at K-State.